Federal judge bars Texas man, source of billions of robocalls nationwide from business
May 29—Ohio and seven other states have received a permanent ban against a Texas-based robocaller behind billions of illegal calls, Ohio Attorney General Dave Yost said in a release.
According to the release, John C. Spiller II previously offered robocall dialer and Voice Over Internet Protocol services to telemarketers, leading to huge volumes of robocalls, many of which targeted numbers on the Do Not Call Registry.
In 2023, he was put under a court order that barred him from placing or facilitating robocalls, but used aliases to launch new companies providing the same kind of robocalls, the release said.
As a result, a federal judge in Texas recently found Spiller in contempt of court and imposed the strictest penalty, permanently barring him from launching future telecommunications companies, operating in the telecom industry, collaborating with those that helped in his illegal businesses, make deceptive statements or use aliases in government filings, the release said.
He was also ordered to pay more than $600,000 in attorney's fees and litigation costs for violating the order.
Attorneys general from Arkansas, Indiana, Michigan, Missouri, North Carolina, North Dakota, Ohio and Texas were involved in the contempt order.
"This scammer's line is dead — and it's not coming back," Yost said.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
24 minutes ago
- Yahoo
If You Can Only Buy 1 Cathie Wood Stock in 2025, It Should Be This
Cathie Wood, founder, CEO and chief investment officer of Ark Invest, continues to make headlines for her high-conviction approach to disruptive innovation. Her flagship fund, the Ark Innovation ETF (ARKK), has posted a 52.9% return in the past 52 weeks, reflecting investor confidence. Known for identifying transformational themes early, Wood maintains focused exposure to industries like genomics, autonomous technology, and blockchain. Within this context, Natera (NTRA) has drawn sharp relevance. The company leads in cell-free DNA testing and precision medicine, aligning directly with Ark's long-term thesis. CoreWeave Just Revealed the Largest-Ever Nvidia Blackwell GPU Cluster. Should You Buy CRWV Stock? AMD Is Gunning for Nvidia's AI Chip Throne. Should You Buy AMD Stock Now? The Saturday Spread: Statistical Signals Flash Green for CMG, TMUS and VALE Tired of missing midday reversals? The FREE Barchart Brief newsletter keeps you in the know. Sign up now! For investors seeking a stock that fits the Ark playbook, Natera may represent one of the most fundamentally aligned additions under Wood's current investment lens. Based in Austin, Texas, stands Natera (NTRA), a pioneer in the field of cell-free DNA and genetic testing. The $23.3 billion biotech firm's arsenal includes powerful offerings like Panorama for prenatal screening, Signatera for real-time cancer surveillance, and Prospera, which sharpens the lens on transplant rejection. Over the last three months, the stock has climbed 16.9%, leaving the broader S&P 500 Index's ($SPX) 5.4% gain behind. On May 8, Natera opened the books on its first-quarter, and the results exceeded Wall Street expectations. Investors responded swiftly, with the stock inching up 1.5% the same day. Natera posted $501.8 million in total revenues, a 36.5% year-over-year increase that soared past Wall Street's $443.3 million forecast. Behind those numbers were powerhouse operations. The company processed 855,100 tests during the quarter, up 16.2% year over year. Women's health volumes climbed meaningfully over the fourth quarter, but it was Signatera that stole the spotlight. The personalized, tumor-informed molecular residual disease test reached new heights, recording its highest volume quarter ever. Clinical volumes for Signatera grew 52% year over year, with a sequential gain of roughly 16,005 units over Q4, marking the most significant quarter-on-quarter growth to date. Gross margins landed at 63.1%, reflecting solid cost discipline. Moreover, Natera's net loss narrowed 1% from the year-ago period to $66.9 million. Also, the company managed to trim its loss per share by 10.7% to $0.50, outperforming analysts' projections of a $0.59 loss per share. As for liquidity, the balance sheet remained in good shape. Cash, cash equivalents and restricted cash climbed to $973.8 million, up from $945.6 million on Dec 31, 2024. CEO Steve Chapman has made no secret of the firm's long-term vision. He believes Signatera could ultimately generate over $5 billion in annual revenue, and he emphasized that they are still playing in the shallow end of a much deeper market pool. In a move that reinforced this optimism, Natera has raised its full-year revenue guidance to between $1.94 billion and $2.02 billion. That is a $70 million boost from the midpoint of its earlier outlook, pointing to a 26% year-over-year growth. On the other hand, analysts expect the Q2 2025 loss per share to widen 100% year over year to $0.60. For FY25, the loss per share is projected to increase 37% to $2.10, but FY26 could bring relief, with a forecast 64.8% narrowing to $0.74, hinting that profitability may finally be within reach. Analysts seem to be singing in harmony when it comes to NTRA, marking it with a firm 'Strong Buy' rating. Out of 19 analysts following the stock, 16 have given it an enthusiastic 'Strong Buy' rating, and the remaining three have placed their bets on a 'Moderate Buy.' The average price target of $200.42 represents potential upside of 17.6%. Meanwhile, the Street-High target of $251 hints at a 48% climb from current levels. Such projections do not come lightly and often reflect deep-rooted confidence in future earnings momentum and strategic execution. On the date of publication, Aanchal Sugandh did not have (either directly or indirectly) positions in any of the securities mentioned in this article. All information and data in this article is solely for informational purposes. This article was originally published on Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
31 minutes ago
- Yahoo
Is It Worth Delaying Claiming Social Security If It Means Withdrawing More From Your 401(k)?
One of the most common dilemmas people face as they near retirement is whether to start collecting Social Security or delay it for a higher monthly benefit. But delaying Social Security often means relying more heavily on other resources, like a 401(k) or other savings, to fill the gap. Is it worth it? Read More: Find Out: 'When it comes to decisions about money, it is a matter of feeling in control and not feeling anxious or stressed,' said Trevor Houston, CEO at ClearPath Wealth Strategies in Frisco, Texas. 'One of the most common questions is whether to wait for the Social Security payments or to take money out of the 401(k) plan early.' Here's what to consider before tapping your 401(k). Delaying your Social Security retirement benefits beyond full retirement age (FRA) results in a higher monthly benefit amount until age 70. 'If you delay taking Social Security, the monthly check will increase by about 8% each year until you reach age 70. That's equivalent to getting a salary increase every year,' Houston explained. 'Pretty nice, right? However, the strategy of waiting only makes sense if you have enough in savings, investments or your 401(k) to cover your bills while you are waiting.' Here are some important factors to consider: Life expectancy: Do you have any serious health conditions? Have your parents and grandparents lived long lives? If you're in good health, waiting could give you a bigger monthly check. On the other hand, Houston explained that if your health or family history suggests a shorter life expectancy, it may make sense to claim Social Security early and use the money while you can. Monthly living expenses: How much money do you need every month to pay your basic living expenses? 'If you start taking out your 401(k) too early, you could end up short later on, especially if the market declines,' Houston said. This is called sequence risk, which could disrupt your retirement plan. A 2024 Vanguard report found that the average 401(k) balance for those age 65 and older is $272,588. However, the average is often skewed by high earners, and the median balance is $88,488. Taxes: Money from your 401(k) is taxed as ordinary income. According to Houston, taking out large sums of money could push you into a higher tax bracket. Safety and security: A stable monthly income provides a feeling of safety and security. 'Some people like to have the Social Security check coming into their account each month. It feels like a regular paycheck, and that provides a great deal of peace of mind during retirement,' he pointed out. Discover More: To show when this strategy might work, Houston provided an example: Let's say David reaches age 66, is in good health, and his parents are in their 90s. His 401(k) balance is around $400,000, and he doesn't need Social Security to pay bills or meet other financial needs. David chooses to delay Social Security and withdrawal from his 401(k) instead. Also, because of his conservative risk tolerance, his 401(k) generates a 5% annual growth rate, less than the 8% annual increase he'd get by waiting on Social Security. 'At the end of the day, waiting for Social Security and using your 401(k) could be a smart strategy if you have enough savings, and you expect to live a long time. But everyone's situation is different,' Houston wrote. 'A financial professional should evaluate your personal goals to determine the best course of action for your specific situation.' More From GOBankingRates 9 Downsizing Tips for the Middle Class To Save on Monthly Expenses This article originally appeared on Is It Worth Delaying Claiming Social Security If It Means Withdrawing More From Your 401(k)? Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
an hour ago
- Yahoo
Senate parliamentarian greenlights state AI law freeze in GOP megabill
The Senate's rules referee late Saturday allowed Republicans to include in their megabill a 10-year moratorium on enforcing state and local artificial intelligence laws — a surprising result for the provision that's split the GOP. Senate Commerce Chair Ted Cruz (R-Texas) rewrote a House-passed AI moratorium to try to comply with the chamber's budgetary rules. His version made upholding the moratorium a condition for receiving billions in federal broadband expansion funds. Both parties made their arguments before the parliamentarian Thursday. "It's good policy," Cruz said of the moratorium in a recent interview. Rep. Jay Obernolte (R-Calif.) has also defended the provision, saying it's necessary to avoid a 'labyrinth of regulation' with '50 different states going 50 different directions on the topic of AI regulation." Though the parliamentarian delivered a victory for Republicans, a number of conservative senators including Sens. Josh Hawley (Mo.) and Marsha Blackburn (Tenn.), have vocally opposed the provision. Hawley has vowed to work with Democrats on an amendment to remove the language once the megabill hits the floor. Rep. Marjorie Taylor Greene (R-Ga.) and the House Freedom Caucus have also opposed the AI moratorium, with Greene threatening to oppose the megabill H.R. 1 (119) if the legal freeze remains.
